Biohaven
BHVN
249 hedge funds and large institutions have $1.23B invested in Biohaven in 2025 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 97 increasing their positions, 70 reducing their positions, and 52 closing their positions.
178% more call options, than puts
Call options by funds: $54.1M | Put options by funds: $19.4M
39% more repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 70
3.56% less ownership
Funds ownership: 88.75% → 85.19% (-3.6%)
6% less funds holding
Funds holding: 266 → 249 (-17)
29% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 52
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
45% less capital invested
Capital invested by funds: $2.22B → $1.23B (-$996M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Voloridge Investment Management
Jupiter,
Florida
|
+$23M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.8M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$13.6M |
| 4 |
Millennium Management
New York
|
+$12.9M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$12.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$116M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$24.7M |
| 3 |
Capital International Investors
Los Angeles,
California
|
-$16.1M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$16.1M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$13.6M |
BHVN Hedge Fund Activity: Q2 2025 in Review
249 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Biohaven (BHVN) for Q2 2025, worth a combined $1.23B — down 45% from $2.22B a quarter earlier.
Sellers outnumbered buyers: 52 funds closed out of BHVN and 37 opened new positions — a net loss of 15 holders — while 70 trimmed existing stakes and 97 added.
The largest buyer was Voloridge Investment Management, adding an estimated $23M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $116M sold.
- 249 institutional investors held Biohaven (BHVN) as of Q2 2025, down from 266 in Q1 2025.
- Funds reported $1.23B of Biohaven stock for Q2 2025, down 45% quarter-over-quarter.
- 37 funds opened new Biohaven positions in Q2 2025 and 52 closed out, a net change of -15 holders.
- The largest Biohaven buyer in Q2 2025 was Voloridge Investment Management, an estimated $23M added.
- The largest Biohaven seller in Q2 2025 was Farallon Capital Management, an estimated $116M sold.
Based on aggregated 13F filings for Q2 2025.